Synopsis: Vodafone Idea’s stock has rallied over 100% in the past year, driven mainly by sentiment improvement, AGR relief, and fundraising expectations. While the company shows early signs of stabilisation in subscriber trends, it still faces high debt and strong...
Synopsis: Prizor Viztech Ltd shares hit 5% upper circuit upon receiving BIS-ER certification under the Compulsory Registration Scheme. The approval covers 10 additional CCTV models, confirming compliance with Indian safety and quality standards and allowing the...
Synopsis: REC Limited shares are in focus as they announced that its Board will meet on June 28, 2026, to consider and approve a merger scheme with Power Finance Corporation Limited under Sections 230–232 of the Companies Act, 2013, subject to regulatory approvals. ...
Synopsis: Rashi Peripherals Ltd shares rose 9% as it is set to acquire a 67% stake in VDA Infosolutions for ₹368.5 crore, with plans to reach 100% ownership by August 2029 through staggered payments. VDA, a digital solutions company, reported ₹850–1,035 crore revenue...
Synopsis: Nomura has maintained an “Accumulate” rating on Dr Reddy’s Laboratories Ltd, raising its target to ₹1,740, implying ~34% upside. The view is driven by a strategic shift toward branded drugs, improving margins, pricing power, and earnings quality. Lower...
Synopsis: Citi placed Cipla Ltd on a 90-day Positive Catalyst Watch, retaining a Buy rating with a ₹1,700 target, implying 20% upside. Growth is driven by a strong US respiratory pipeline, regulatory clearances, and recovery in India business. Earnings bottoming,...
Synopsis: The share of this company, a GovTech and digital solutions player, is launching a Rs 146 crore IPO to fund growth, repay debt, and support expansion plans. CSM Technologies Ltd IPO has launched its Initial Public Offering (IPO) today, which is to benefit...
Synopsis: Kirloskar Oil Engines Limited shares jumped 34% in two sessions after securing a major 192 MW data-centre order from HyperNext. The win strengthened confidence in its data-centre and HHP engine growth strategy, while brokerage upgrades, solid financial...
Synopsis: Four Indian defence sector companies delivered wealth creation over the past year, driven by indigenisation, rising defence spending, and Make in India initiatives. MTAR Technologies, Paras Defence, Data Patterns, and Astra Microwave showed significant stock...
Synopsis: USFDA has reportedly approached Indian pharma firms amid a US shortage of cancer drug ifosfamide caused by manufacturing issues at Baxter. The shortage may persist till 2026, creating supply opportunities. Cipla, Alkem Laboratories, and Zydus Lifesciences...
